Dupilumab for treatment-refractory prurigo nodularis

Bálint Kovács; Ellen Rose; Nadine Kuznik; Iakov Shimanovich; Detlef Zillikens; Ralf J. Ludwig; Diamant Thaçi

doi:10.1111/ddg.14107

Dupilumab for treatment-refractory prurigo nodularis

Bálint Kovács^*, Ellen Rose, Nadine Kuznik, Iakov Shimanovich, Detlef Zillikens, Ralf J. Ludwig, Diamant Thaçi

^*Corresponding author for this work

Original language	English
Journal	JDDG - Journal of the German Society of Dermatology
Volume	18
Issue number	6
Pages (from-to)	618-624
Number of pages	7
ISSN	1610-0379
DOIs	https://doi.org/10.1111/ddg.14107
Publication status	Published - 01.06.2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Access to Document

10.1111/ddg.14107

Cite this

@article{228c6214f2aa4880bceecc5b7555a41b,

title = "Dupilumab for treatment-refractory prurigo nodularis",

author = "B{\'a}lint Kov{\'a}cs and Ellen Rose and Nadine Kuznik and Iakov Shimanovich and Detlef Zillikens and Ludwig, \{Ralf J.\} and Diamant Tha{\c c}i",

year = "2020",

month = jun,

day = "1",

doi = "10.1111/ddg.14107",

language = "English",

volume = "18",

pages = "618--624",

journal = "JDDG - Journal of the German Society of Dermatology",

issn = "1610-0379",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "6",

}

TY - JOUR

T1 - Dupilumab for treatment-refractory prurigo nodularis

AU - Kovács, Bálint

AU - Rose, Ellen

AU - Kuznik, Nadine

AU - Shimanovich, Iakov

AU - Zillikens, Detlef

AU - Ludwig, Ralf J.

AU - Thaçi, Diamant

PY - 2020/6/1

Y1 - 2020/6/1

UR - https://www.scopus.com/pages/publications/85086095830

U2 - 10.1111/ddg.14107

DO - 10.1111/ddg.14107

M3 - Letters

C2 - 32469446

AN - SCOPUS:85086095830

SN - 1610-0379

VL - 18

SP - 618

EP - 624

JO - JDDG - Journal of the German Society of Dermatology

JF - JDDG - Journal of the German Society of Dermatology

IS - 6

ER -

Dupilumab for treatment-refractory prurigo nodularis

UN SDGs

Research Areas and Centers

Access to Document

Other files and links

Cite this